Alexandra Nugent
Family · New York, NYNPI 1558952879
Payments from drug & device makers
Across 129 payments — averaging $23.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$764
- Gilead$501
- Lilly USA, LLC$334
- AbbVie$267
- Novo Nordisk$193
- Neos Therapeutics, LP$136
- plus $790 from 17 others
What the payments were for
- Food & beverage$2,973100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 29 | $764 |
| Gilead | 20 | $501 |
| Lilly USA, LLC | 15 | $334 |
| AbbVie | 12 | $267 |
| Novo Nordisk | 9 | $193 |
| Neos Therapeutics, LP | 6 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $129 |
| Corium, LLC | 3 | $88 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $79 |
| Merck | 4 | $66 |
| AstraZeneca | 3 | $56 |
| GSK | 3 | $54 |
| Dynavax Technologies Corporation | 2 | $44 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $42 |
| Phadia US Inc. | 2 | $37 |
| Almatica Pharma LLC | 2 | $36 |
| Corcept Therapeutics | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Exact Sciences | 1 | $23 |
| Amgen | 1 | $22 |
| Aytu Biopharma, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APRETUDE$120
How this compares
$2,984 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 48 | $455 |
| Rosuvastatin Calcium | 14 | $397 |
| Amlodipine Besylate | 23 | $198 |
| Tamsulosin Hcl | 13 | $114 |
| Losartan Potassium | 14 | $81 |
| Trazodone Hcl | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other family in New York
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Thomas SaglimbeniNew York$48K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.